O015 Establishment of a Monitoring Service for Men Who Have Sex With Men (MSM) Taking Generic Co-Formulated Tenofovir Disoproxil Fumarate (TDF)/emtricitabine (FTC) as Pre-Exposure Prophylaxis (PrEP) Against HIV Infection

Sexually Transmitted Infections - United Kingdom
doi 10.1136/sextrans-2016-052718.14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Correction: Optimal Costs of HIV Pre-Exposure Prophylaxis for Men Who Have Sex With Men

PLoS ONE
Multidisciplinary
2017English

Optimizing Content for Pre-Exposure Prophylaxis (PrEP) Counseling for Men Who Have Sex With Men: Perspectives of PrEP Users and High-Risk PrEP Naïve Men

AIDS and Behavior
EnvironmentalPublic HealthInfectious DiseasesSocial PsychologyOccupational Health
2013English

Challenges for HIV Pre-Exposure Prophylaxis Among Men Who Have Sex With Men in the United States

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2012English

Pre-Exposure Prophylaxis for HIV Prevention Preferences Among Young Adult African American Men Who Have Sex With Men

PLoS ONE
Multidisciplinary
2018English

Understanding Willingness to Use Oral Pre-Exposure Prophylaxis for HIV Prevention Among Men Who Have Sex With Men in China

PLoS ONE
Multidisciplinary
2018English

Recently Acquired HIV Infection in Men Who Have Sex With Men (MSM) in France, 2003-2008

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2009English

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Knowledge and Attitudes of Syphilis and Syphilis Pre-Exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men in Vancouver, Canada: A Qualitative Study

BMJ Open
Medicine
2019English

Switching to Coformulated Rilpivirine (RPV), Emtricitabine (FTC) and Tenofovir Alafenamide From Either RPV, FTC and Tenofovir Disoproxil Fumarate (TDF) or Efavirenz, FTC and TDF: 96-Week Results From Two Randomized Clinical Trials

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy